Status:

COMPLETED

Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis

Lead Sponsor:

Xuanwu Hospital, Beijing

Conditions:

Ischemic Stroke

Eligibility:

All Genders

35-75 years

Brief Summary

The study hypothesizes that Drug -eluting stents are more effective in preventing restenosis than Bare-metal stents after Vertebral Artery Ostium stenting

Detailed Description

The vertebral artery ostium stenosis was one of the higher risk of the ischemia stroke in China. In the mean time ,more and more people accept revascularization. There are no prospective studies for c...

Eligibility Criteria

Inclusion

  • \- symptomatic posterior circulation ischemia including monor stroke (mRS ≤2) or TIA result from the stenosis in the vertebral artery ostium.
  • 70% to 99% stenosis of vertebral artery ostium.

Exclusion

  • etiology of stenotic lesions not atherosclerosis patients had undergone previos interventions on the vertebral artery ostium ipsilateral severe stenotic lesions in subclavian artery involved as well as vertebral artery ostium

Key Trial Info

Start Date :

January 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2016

Estimated Enrollment :

168 Patients enrolled

Trial Details

Trial ID

NCT02197559

Start Date

January 1 2014

End Date

June 1 2016

Last Update

October 24 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of neurosurgery, Xuanwu hospital

Beijing, China, 100053

Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis | DecenTrialz